Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo.

BACKGROUND & AIMS Recent studies identified bone morphogenic protein 6 (BMP6) as a key regulator of hepatic hepcidin expression and iron metabolism, but the cellular source of BMP6 and the reason for its specific effect on hepatocytes are unknown. METHODS BMP and hepcidin expression upon iron sensing were analyzed in vivo in BMP6(-/-) and BMP6(+/+) mice and ex vivo in tissue and in vitro in cells of the liver and the small intestine. RESULTS BMP6(-/-) mice developed severe hepatic iron accumulation and reduced hepcidin expression with increasing age. This phenotype could be triggered in younger BMP6(-/-) mice by dietary or parenteral iron application. Furthermore, both treatments induced a marked up-regulation of BMP6 expression in the small intestine of BMP6(+/+) mice. Ex vivo treatment of intestinal tissue of BMP6(+/+) mice with iron sulfate or holo-transferrin confirmed epithelial cells as an inducible source of BMP6. In contrast, iron overload did not promote a striking induction of BMP6 expression in hepatocytes or macrophages. Furthermore, iron-supplemented diet induced a compensatory up-regulation of BMP2, BMP4, and BMP9 in the small intestine of BMP6(-/-) mice that was apparently not sufficient to assure iron homeostasis. As a potential explanation, analysis of hepatocytes revealed an expression pattern of BMP receptor subunits preferentially used by BMP6, and treatment of hepatocytes with different recombinant BMPs identified BMP6 as the most potent stimulator of hepcidin expression. CONCLUSIONS Epithelial cells of the small intestine are the predominant cellular source of BMP6 upon iron sensing. Our findings reveal a previously unknown mechanism in which the small intestine controls iron homeostasis.

[1]  M. Roth,et al.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.

[2]  S. Vukicevic,et al.  BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.

[3]  M. Chandy,et al.  Iron homeostasis: new players, newer insights , 2008, European journal of haematology.

[4]  J. Mosser,et al.  Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. , 2008, Blood.

[5]  A. Kotzsch,et al.  Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand , 2008, The FEBS journal.

[6]  B. Bacon,et al.  Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse , 2007, BMC Genomics.

[7]  A. Bosserhoff,et al.  Reduced expression of TANGO in colon and hepatocellular carcinomas. , 2007, Oncology reports.

[8]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[9]  K. Batts.  Iron overload syndromes and the liver , 2007, Modern Pathology.

[10]  A. Marais,et al.  Effects of iron overload in a rat nutritional model of non‐alcoholic fatty liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[11]  E. Beutler,et al.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 , 2006, Proceedings of the National Academy of Sciences.

[12]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[13]  C. Hellerbrand,et al.  PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis , 2006 .

[14]  C. Deng,et al.  A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. , 2005, Cell metabolism.

[15]  V. Gordeuk,et al.  Benefits and risks of iron therapy for chronic anaemias , 2005, European journal of clinical investigation.

[16]  L. Goodnough,et al.  Anemia of chronic disease. , 2005, The New England journal of medicine.

[17]  E. Beutler,et al.  Regulation of hepcidin transcription by interleukin-1 and interleukin-6. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[19]  M. Hentze,et al.  Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.

[20]  P. Brissot,et al.  Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. , 2004, Blood cells, molecules & diseases.

[21]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[22]  C. Hellerbrand,et al.  Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique. , 2001, Scandinavian journal of gastroenterology.

[23]  K. Miyazono,et al.  Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. , 2001, Journal of cell science.

[24]  R. Derynck,et al.  Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo , 1994, The Journal of cell biology.

[25]  A. R. Muir,et al.  Hepatic pathology in relatives of patients with haemochromatosis. , 1962, The Journal of pathology and bacteriology.

[26]  Charles C Hong,et al.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.

[27]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[28]  B. Hogan,et al.  Mice lacking Bmp6 function. , 1998, Developmental genetics.